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Abstract 
This review discusses synthesis of enantiopure sulfoxides through the asymmetric oxidation 
of prochiral sulfides. The use of metal complexes to promote asymmetric sulfoxidation is 
described in detail, with a particular emphasis on the synthesis of biologically active 
sulfoxides. The use of non-metal based systems, such as oxaziridines, chiral hydroperoxides 
and peracids, as well as biologically-catalyzed sulfoxidations is also examined.  
 
Keywords: Sulfide oxidation, sulfoxides, asymmetric synthesis, enantioselective synthesis, 
metal-based catalysts. 
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1. Introduction 
Enantiopure sulfoxides are important reagents in asymmetric synthesis due to their use as 
chiral auxiliaries in a broad range of synthetic reactions such as Diels Alder reactions (1-3), 
Michael addition reactions (4), carbon-carbon (5,6) and carbon-oxygen (7) bond forming 
reactions. The use of chiral sulfoxides as auxiliaries in asymmetric synthesis has been 
discussed in a number of reviews.(8-12) A large number of sulfoxides, such as the gastric 
acid inhibitors omeprazole [1], lansoprazole [2], rabeprazole [3] and  pantoprazole [4]  have 
found use in the pharmaceutical industry.  
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The three main routes to enantiopure sulfoxides are asymmetric sulfoxidation, nucleophilic 
substitution using a chiral sulfur precursor and kinetic resolution of racemic sulfoxides (13-
17). This review will discuss the asymmetric oxidation of sulfides promoted by metal 
complexes and non-metal based systems such as chiral oxaziridines, peracids, 
hydroperoxides, and biological systems, with a particular emphasis on the synthesis of 
biologically active sulfoxides. It will focus primarily on the asymmetric oxidation of acyclic 
aryl alkyl sulfides while the oxidation of dialkyl sulfides, cyclic sulfides and disulfides will 
also be briefly explored.  
2. Metal-catalyzed asymmetric sulfoxidation 
The most attractive method for the preparation of enantiopure sulfoxides is metal-catalyzed 
asymmetric sulfide oxidation because these oxidizing systems can, in general, be applied to a 
wide range of substrates and only a catalytic amount of the metal complex is required. 
Although titanium and vanadium complexes have found the most use in asymmetric 
sulfoxidation, other metal based systems such as iron and copper have emerged in recent 
years.  
2.1 Titanium complexes 
In 1984, the research groups of Kagan (18) and Modena (19) independently reported the use 
of a titanium complex in the asymmetric oxidation of sulfides. The systems used to carry out 
the oxidations were based on the Sharpless asymmetric epoxidation procedure. (20) Kagan et 
al. (18,21) used a titanium complex prepared from Ti(Oi-Pr)4, (R,R)-diethyl tartrate (DET) 
and water in the ratio 1:2:1 with tert-butyl hydroperoxide (TBHP) as oxidant (Scheme 1). 
Although stoichiometric amounts of the titanium complex were initially required to produce 
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sulfoxides in high enantioselectivities, a subsequent publication reported the use of a catalytic 
alternative with only a slight reduction in enantioselectivity (22). Replacement of TBHP with 
cumyl hydroperoxide (CHP) led to an improvement in enantioselectivity. The Modena 
method is very similar to Kagan’s, but uses Ti(Oi-Pr)4/DET in a ratio of 1:4, dichloroethane 
(DCE) as solvent and is carried out in the absence of water (19). The Modena system was 
used to oxidize methyl p-tolyl sulfide [5], producing the corresponding sulfoxide [6] in high 
enantioselectivity (Scheme 2). 
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Scheme 2 Modena Oxidation 
 
A number of other research groups have carried out titanium-catalyzed sulfoxidations using 
different chiral ligands to that employed by Kagan. Imamoto et al. (23) used the diol [7] as a 
chiral ligand for the asymmetric oxidation of methyl p-tolyl sulfide [5]. This system used 
CHP as oxidant and produced methyl p-tolyl sulfoxide [6] in moderate yield (42%) and 
excellent enantioselectivity [95% enantiomeric excess (ee)]. Interestingly, Imamoto observed 
that the oxidation using [7] proceeded with the highest degree of enantiopurity when 
conducted in the presence of molecular sieves. This was in contrast to Kagan’s study which 
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demonstrated that the presence of water was crucial for the enantioselectivity of the 
oxidation. Uemura et al. (24) also investigated the effect of water in the Kagan system and 
concluded that the presence of too much or too little water in the reaction could impact 
detrimentally on the enantioselectivity of the oxidation. 
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Uemura (25) also reported titanium-catalyzed oxidation using binaphthol (BINOL) [8] as 
chiral ligand and TBHP as oxidant. This system produced methyl p-tolyl sulfoxide [6] in 
moderate yield (43%) and excellent enantioselectivity (up to 96% ee, Scheme 3).  
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Scheme 3 Uemura Oxidation 
 
A number of other research groups have also used binaphthol derivatives as chiral ligands to 
asymmetrically oxidize sulfides. Bolm et al. (26) used a steroid derived BINOL derivative [9]  
to oxidize [5], producing sulfoxide [6] in excellent enantioselectivity (92% ee). Bolm 
reported that an addition of water was crucial for the enantioselectivity of the oxidation. 
Martyn et al. (27) investigated the effect of fluorine substitution at a number of positions of 
BINOL on its catalytic activity in titanium-mediated sulfide oxidation. Sulfoxide [6] was 
produced in moderate yield (55%) and good enantioselectivity (80% ee) using [10], while the 
use of [8] as chiral auxiliary afforded [6] in moderate yield (69%) but poor enantioselectivity 
(3% ee). Interestingly, the (R) enantiomer is preferentially formed using [10] while the (S) 
enantiomer is favoured using [8].  
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Rosini et al. (28) also used a diol [11] as chiral ligand to asymmetrically oxidize aryl methyl 
sulfides. The sulfoxide [6] was produced in moderate yield (62%) and good enantioselectivity 
(80% ee). Recently, Rosini (29) has used a similar diol [12] to oxidize benzyl phenyl sulfide 
[13], producing sulfoxide [14] in moderate yield and excellent enantioselectivity (Scheme 4). 
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Scheme 4 Chiral Diol as a Ligand 
Zeng et al. (30) used camphanediols such as [15] to oxidize thioanisole [16], producing the 
sulfoxide of thioanisole [17] in poor yield but with excellent enantioselectivity (up to 99% 
ee). Zeng speculated that the oxidation occurs by an intramolecular nucleophilic oxygen 
transfer to the coordinated sulfide. 
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Zhu et al. (31) used 2,5-dialkyl cyclohexane-1,4-diols such as [18] to produce a variety of 
enantioenriched aryl methyl sulfoxides (up to 84% ee) in moderate to good yields (up to 
79%). 
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Titanium-salen complexes have also been used to asymmetrically oxidize sulfides. Katsuki 
reported the use of Ti (salen) complex [19] for the asymmetric oxidation of a number of aryl 
alkyl sulfides. The best results were obtained when the oxidation was carried out at 0 °C 
using urea hydrogen peroxide adduct (UHP) as oxidant. This system afforded methyl p-
chlorophenyl sulfoxide [20] in excellent yield (88%) and excellent enantioselectivity (99% 
ee) (32,33). 
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Bryliakov and Talsi (34) reported tiatanium-catatlysed asymmetric sulfoxidation using 
titanium-salen complexes similar to that used by Katsuki. This system afforded benzyl phenyl 
sulfoxide [14] in a moderate conversion (65%) and excellent enantioselectivity (97% ee) by a 
combination of asymmetric oxidation and kinetic resolution. Bryliakov (35) also reported a 
titanium-mediated oxidation using an amino alcohol derived Schiff base ligand [21] and 
hydrogen peroxide as oxidant. This system afforded benzyl phenyl sulfoxide [14] in excellent 
conversion (96%) and modest enantioselectivity (60% ee). 
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The use of chiral hydroperoxides in titanium-mediated sulfoxidations has been examined. 
Adam et al. (36) used hydroperoxide [22] to oxidize methyl p-tolyl sulfide [5], producing 
sulfoxide [6] in a moderate conversion (69%) and good enantioselectivity (75% ee). Kinetic 
resolution accompanied these oxidations which resulted in reduced yield due to over-
oxidation, but improved enantioselectivity. 
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Scettri and co-workers (37-40) used an enantioenriched form of the secondary furyl 
hydroperoxide [23] to oxidize thioanisole [16], affording sulfoxide [17] in good yield (75%) 
and excellent enantioselectivity (95% ee). Interestingly, the oxidation of the sulfide resulted 
in kinetic resolution of [23]. This system used DET as the chiral ligand. Scettri et al. (41) also 
used a variety of norcamphor-derived furyl hydroperoxides such as [24]. The use of a chiral 
ligand with these peroxides is not necessary. Scettri speculated that steric interactions 
between the oxidant and sulfide resulted in preferential formation of one sulfoxide 
enantiomer. The best result was obtained for the oxidation of para-methoxyphenyl methyl 
sulfide [25], producing sulfoxide [26] in poor yield and moderate enantioselectivity (Scheme 
5). Significant sulfone formation accompanied this oxidation. 
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Scheme 5 Chiral Hydroperoxides 
 
Liebscher (42) used a chiral peroxide [27] derived from (R)-menthyl chloroformate, 4-
bromoisoquinoline and TBHP. complementary kinetic resolution accompanied this oxidation. 
The use of 3.3 equivalents of hydrogen peroxide as oxidant afforded sulfoxide [17] in poor 
yield (16%) and excellent enantioselectivity (>99% ee), with a large amount of over-
oxidation to sulfone. 
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Cardellicchio et al. (43) asymmetrically oxidized aryl benzyl sulfides using a titanium 
complex composed of hydrobenzoin [28] as the catalyst. The system was used to oxidize 
sulfide [29], producing sulfoxide [30] in good yield and excellent enantioselectivity (Scheme 
6).  
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Scheme 6 Chiral Diol in Titanium-mediated Oxidation 
The mechanism of this system has been investigated (44). Cardellicchio et al. hypothesized, 
based on NMR studies of the reaction mixture, that a simple tetrahedral complex between 
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titanium and two molecules of the ligand is formed in solution when titanium 
tetraisopropoxide and hydrobenzoin are mixed. This tetrahedral complex is approached first 
by the sulfide, and then by the oxidant, thus yielding an octahedral complex. A simplified 
model of the octahedral complex was reported in 2011 and is shown in Figure 1.  
 
Figure 1 Octahedral titanium-hydrobenzoin complex (reproduced with permission from 
reference (44) 
Cardellicchio reported a strong hydrogen bond between the acidic hydrogen atom of the 
TBHP and one oxygen atom of a hydrobenzoin ligand. A CH-π interaction was proposed 
between hydrogen of one hydrobenzoin and a phenyl group of the aryl benzyl sulfide. 
Weaker interactions between the π systems of other aryl groups are present in the rear part of 
the structure. The absence of these stabilizing interactions in the octahedral complex leading 
to the other enantiomer accounted for the high enantioselectivity achieved using this system. 
A number of research groups have reported the use of immobilized catalysts. Iwamoto et al. 
(45) used the Kagan methodology employing a titanium catalyst which was immobilized on 
mesoporous silica. However, only moderate enantioselectivities were obtained (up to 30% 
ee).  
Similarly, Gao et al. (46) used a soluble polyethylene glycol (PEG)-supported tartrate chiral 
ligand [31] to oxidize sulfide [32], producing sulfoxide [20] in excellent yield and excellent 
enantioselectivity (Scheme 7). 
 
11 
 
Ti(Oi
-Pr)4
, CHP
 
-20
 °C,
 
CH2Cl2
S S
O
20
99%
 ee (S)
91%
 
Yield
32Cl
31
HO
O
OPEGOMe
HO
O
O
n-Hept
Cl
 
Scheme 7 Use of Immobilized Catalyst by Gao to promote Asymmetric Oxidation 
Yuan et al. (47) used a titanium complex composed of the naphthol derived compound [33] 
to oxidize methyl p-tolyl sulfide [5], producing sulfoxide [6] in moderate yield (50%) and 
excellent enantioselectivity (99% ee). TBHP was used as oxidant and the oxidation was 
carried out in a toluene-tetrahydrofuran (THF) (1:1) solvent mixture. 
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Sahoo et al. (48) used an immobilized titanium-BINOL complex to prepare enantiopure aryl 
methyl sulfoxides. Complementary kinetic resolution accompanied these oxidations. The 
immobilized catalyst could be used in multiple runs without any loss of either 
enantioselectivity or activity. 
Rodygin et al. (49) recently reported the asymmetric oxidation of a range of fluorine 
containing sulfides using the Kagan system. Sulfide [34] was oxidized to sulfoxide [35] in 
good yield and enantioselectivity (Scheme 8). 
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Scheme 8 Titanium-Catalyzed Oxidation of Fluorine-containing Sulfides  
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2.1.1 Synthesis of biologically active sulfoxides using titanium complexes 
Titanium complexes have been used to synthesise pharmaceutical agents. A modified Kagan 
system was used by Von Unge (50) to prepare esomeprazole [1] in high enantioselectivity 
from the corresponding sulfide [36] (Scheme 9). Unlike the original Kagan procedure, the 
catalyst complex was prepared in the presence of the sulfide at an elevated temperature. The 
addition of N,N-diisopropylethylamine to the reaction mixture was necessary for the 
enhanced enantioselectivity.   
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Scheme 9 Synthesis of Esomeprazole using a modified Kagan Procedure 
Jiang et al. (51) used a brominated aromatic diol [37] in the asymmetric synthesis of 
esomeprazole [1]. This system employed TBHP as oxidant and produced esomeprazole in 
high yield and enantioselectivity (Scheme 10). 
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Scheme 10 Synthesis of Esomeprazole using Brominated Aromatic Diol 
Zhu et al. (31) used [18] as a chiral ligand in the asymmetric oxidation of sulfide [36], 
affording esomeprazole [1] in good yield (72 %) and enantioselectivity (76% ee).  
Volcho et al. (52) also reported a titanium-catalyzed asymmetric oxidation of omeprazole 
sulfide [36]. This system used CHP as oxidant and (R)-N,N-dimethyl-1-phenylethylamine 
[38] as a chiral ligand, producing the sodium salt of [1] in 64% yield and > 99.5% ee. 
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Delamare et al. (53) reported the asymmetric synthesis of (S)-tenatoprazole [39] using a 
titanium complex with (+)-(1R, 2S)-cis-1-amino-2-indanol [40] as the chiral ligand. The 
procedure involved the use of the polar aprotic solvent N-methyl-2-pyrrolidone (NMP) and 
afforded [39] in high yield (90%) and enantioselectivity (> 99% ee). 
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Raju et al. (54) used the Kagan system in the asymmetric synthesis of dexlansoprazole [2]. 
(R)-[41] was obtained in excellent enantioselectivity and then converted to [2] as shown in 
Scheme 11.  
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Scheme 11 Asymmetric Synthesis of Dexlansoprazole using a Titanium Complex 
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Caturla et al. (55,56) used the Modena system for the asymmetric synthesis of sulfoxides 
[42], [43] and [44] in modest yield (17-60%) and excellent enantioselectivity (88-100% ee). 
These sulfoxides have the potential to act as prodrugs of the corresponding sulfones which 
are potent COX-2 inhibitors.  
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Maguire et al. (57) used the Kagan system for the asymmetric oxidation of sulfide [45]. 
Sulfoxide [46] was obtained in modest yield and excellent enantioselectivity, and was then 
converted to sulindac [47] as shown in Scheme 12. 
Naso et al. (58) reported high ee (94-96% ee) and moderate yields (48-50%) in the 
preparation of sulindac alkyl esters using the hydrobenzoin complex [28].  
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Scheme 12 Asymmetric Synthesis of Sulindac using a Titanium Complex 
Cephalon (59) has reported the enantioselelctive synthesis of ®-modafinil [48] (up to 99% 
ee) from the corresponding sulfide. This system used CHP as oxidant and DET as the chiral 
ligand. The addition of a tertiary amine to the reaction was crucial to achieve high 
enantioselectivities.  
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Matsugi et al. (60-62) used mandelic acid [49] as a chiral ligand to oxidize sulfide [50] to 
produce sulfoxide [51] on a large scale (Scheme 13). Sulfoxide [51], which is a key 
intermediate in the synthesis of the platelet adhesion inhibitor [52], was obtained in excellent 
yield and good enantioselectivity from the corresponding sulfide [50], and was subsequently 
recrystallized to afford enantiopure [52]. This system is extremely useful because the reaction 
proceeds at ambient temperature and mandelic acid [49] can be readily recovered by 
extracting with a weak base.  
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Scheme 13 Use of Mandelic Acid in Titanium-mediated Oxidation 
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2.2 Vanadium complexes 
Vanadium complexes composed of tridentate Schiff bases have been used to catalyze 
asymmetric sulfoxidation. Fujita et al. (63) used vanadium Schiff base complex [53] as the 
catalyst and CHP as oxidant for the oxidation of thioanisole [16] producing sulfoxide [17] in 
modest enantiopurity (up to 40% ee). Fujita (64)  later reported the use of Schiff base ligands 
derived from salicylaldehyde and L-amino acids, such as [54], however, enantioselectivities 
remained poor for the oxidation of thioanisole (up to 14% ee).  
N N
O O
V
O
OR RO
R
 = Me
 or Et
53
O
N O
O
V
OCH3O
R
MeOH
O
NO
O
V
H3CO O
MeOH
54
 EXO 54
 ENDO
R
 
A dramatic improvement to this oxidizing system was reported by Bolm et al. (65) in 1995. 
Vanadium complexes derived from Schiff bases such as [55] and VO(acac)2 were used to 
catalyze the oxidation of a variety of aryl alkyl sulfides, producing sulfoxides in modest to 
good enantiopurities (50 to 70% ee). In a subsequent publication (66), Bolm reported the 
asymmetric monooxidation of dithioketals and dithioacetals, producing monosulfoxides with 
very good enantiopurities (up to 85% ee).  
The Bolm system is superior to other oxidation methods because it employs hydrogen 
peroxide, a cheap and environmentally benign oxidant, and the oxidizing species is extremely 
active, with asymmetric oxidation occurring even in the presence of 0.1 mol% of the catalyst. 
The Schiff base ligands can be synthesized very easily by reacting the appropriate 
salicylaldehyde with enantiopure aminoalcohols such as L-tert leucinol. 
Bolm investigated the effect of ligand structure on the oxidation, and reported that the 
optimum ligand was substrate specific. The use of ligand [55] afforded methyl phenyl 
sulfoxide [17] in 70% ee and the dithioacetal monosulfoxide [56] in 76% ee. However, use of 
ligand [57] produced sulfoxides [17] and [56] in 59% and 85% ee respectively (66) (Scheme 
14). 
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Scheme 14 Optimum Ligand is Substrate Specific 
Ellman et al. (67,68) also investigated the effect of ligand structure on the asymmetric 
oxidation of tert-butyl disulfide [58]. A tert-butyl group was required in the R1 position of the 
ligand to achieve the highest enantiopurities, while the substituent at the R2 position played 
no steric role in the oxidation although its electronic effects were important (Figure 2). The 
steric and electronic effects of the substituent in the R3 position of the Schiff base ligand were 
significant. Overall, ligand [57] was optimum for the oxidation of disulfide [58], producing 
the monosulfoxide [59] in good enantioselectivity as shown in Scheme 15. Ellman (67) 
reported improved enantioselectivity (91% ee) on carrying out the oxidation of [58] in CHCl3 
rather than CH2Cl2. 
R2
R3
OH N
HO
R1
 
Figure 2 Structure of Schiff Base Ligand 
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Scheme 15 Asymmetric Oxidation of a Disulfide 
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Jackson et al. (69,70) screened a library of ligands obtained from a solid-supported aldehyde 
and different amino alcohols. A large number of ligands were tested for the oxidation of 
thioanisole with ligands [60] and [61] producing the best results. 
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Gao et al. (71) also investigated the effect of ligand structure on the asymmetric oxidation of 
sulfides. The results of this study demonstrated that using the isopropyl substituted Schiff 
base ligands [62] and [63], derived from (S)-valinol, resulted in higher enantioselectivity than 
that achieved with their isobutyl analogues (81% ee using [62], 88% ee using [63], and 71% 
ee and 75% ee for their respective isobutyl analogues)for the oxidation of thioanisole [16].  
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Maguire et al. (72,73) carried out vanadium-catalyzed oxidations using ligands similar to 
those used by Bolm. This report focussed on the asymmetric oxidation of aryl benzyl 
sulfides, in contrast to Bolm’s study of aryl alkyl sulfides. An important feature of this 
oxidation is that it is accompanied by complementary kinetic resolution which resulted in 
improved enantioselectivities, albeit with reduced yields as a result of over oxidation. A 
number of Schiff base ligands was investigated with ligand [60] producing the best results. 
Sulfide [64] was oxidized to the corresponding sulfoxide [65] in modest yield but excellent 
enantioselectivity with significant over oxidation to sulfone [66] as shown in Scheme 16. 
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Scheme 16 Vanadium-Catalyzed Oxidation of Aryl Benzyl Sulfides 
Liu et al. (74) synthesized a series of chiral Schiff bases with different substituents on the 
salicylidenyl unit. Schiff base [67] produced the best results in the oxidation of 2-naphthyl 
methyl sulfide [68], affording sulfoxide [69] in good yield (85%) and excellent 
enantioselectivity (90% ee). An investigation of solvent indicated that chlorinated solvents 
such as CH2Cl2 and CHCl3 produced sulfoxides with the highest enantiopurities.  
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Li et al. (75) synthesized a number of novel Schiff base ligands with two stereogenic centres. 
Ligand [70] was used to convert a variety aryl alkyl sulfides into the corresponding 
sulfoxides with good yields and excellent enantioselectivities (up to 99% ee). The choice of 
solvent had a large influence on enantioselectivity, with CHCl3 significantly outperforming 
CH2Cl2. Complementary kinetic resolution accompanied this oxidation which led to a slight 
enhancement in enantioselectivity. 
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In 2009, Koneva et al. (76) reported the synthesis of a series of new chiral Schiff bases, such 
as [71], derived from the monoterpene, (+)-3-carene. However the use of these ligands in the 
asymmetric oxidation of thioanisole [16] afforded sulfoxide [17] with very poor 
enantiopurities (up to 20% ee). In another publication (77), Koneva outlined the use of α-
pinene derived ligands [72] for asymmetric sulfoxidation; however enantioselectivities 
remained low (up to 32% ee). 
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Barbarini et al. (78) synthesized a series of polymer-supported chiral Schiff bases, such as 
[73], composed of salicylaldehyde deivatives and optically active amino alcohols. Moderate 
enantioselectivities were obtained, in the oxidation of thioanisole, when the ligand was 
supported on a polystyrene matrix (~56% ee), while the use of polyester supports resulted in 
a significant reduction in enantioselectivity (~39% ee). However, overall the 
enantioselectivities were considerably lower than those obtained using the “free” vanadium 
complex.  
Zeng et al. (79) reported the use of pre-formed complexes, such as [74], in asymmetric 
sulfoxidation. Schiff bases were prepared by condensation of a salicylaldehyde derivative 
with a chiral amino alcohol. VO(acac)2 and the Schiff base were then refluxed for 3 hours in 
methanol to generate the complex, which appears as a brown precipitate. The use of these 
complexes, with hydrogen peroxide as oxidant, afforded sulfoxide [17] in excellent yield but 
poor enantioselectivity. However, increasing the amount of oxidant afforded [17] in modest 
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yield (41%) and excellent enantioselectivity (up to 99% ee) as a result of complementary 
kinetic resolution. The pre-formed complexes were also used to oxidize various substituted 
sulfides with good enantiocontrol. 
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Recently, Zeng (80) used a vanadium Schiff base complex to oxidize allyl phenyl sulfide, 
obtaining the corresponding sulfoxide in moderate yield and excellent enantioselectivity 
(Scheme 17). Carrying out the oxidation using an increased amount of oxidant resulted in 
reduced yields but an improvement in enantioselectivity indicating that kinetic resolution was 
taking place.  
S S
O
N
OI
I
O
V
OEt
30%
 
H2O2
 
(1
.6
 equiv.)
 
CH2Cl2
, 16h,
 
0
 °C
2
 mol% S+
O O
 
Sulfoxide
 : 58%,
 
93%
 ee (S),
 
Sulfone
 : 16%
1.6
 equiv.
 
H2O2
 
Sulfoxide
 : 75%,
 
72%
 ee (S),
 
Sulfone
 : 0%
1.2
 equiv.
 
H2O2
O
 
Scheme 17 Asymmetric Oxidation of Allyl Phenyl Sulfide using a Vanadium Complex 
Lippold et al. (81) reported the use of pre-formed vanadium complexes, such as [75], derived 
from 6-amino-6-deoxyglucopyranoside. Complex [75] was used to oxidize thioanisole [16] 
and benzyl phenyl sulfide [13], producing the corresponding sulfoxides in good to excellent 
yields (91% for [17] and 77% for [14]) but poor enantioselectivity (26% ee for [17] and 16% 
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ee for [14]). Interestingly, the use of TBHP as oxidant, instead of hydrogen peroxide, 
afforded racemic sulfoxide. 
Romanowski and co-workers (82,83) investigated asymmetric sulfoxidation using pre-formed 
complexes, derived from chiral diamine Schiff bases [76] and [77]; however, only modest 
enantiopurities were achieved (up to 39% ee).  
OH
R2
N *
*
H2N
Ph
R1
Ph
76 R1 = H, R2 = OMe
77 R1 =  OMe,
 
R2
 = H
RR
O
N
O
OO
O
O
VO
O
75  
Trimeric variants of Bolm’s catalysts were synthesized by Pati et al. (84) (Figure 3) and used 
in the oxidation of both aryl methyl and aryl benzyl sulfides. Pati et al. reported improved 
enantioselectivities using vanadium catalysts derived from ligands with the three salen 
moieties separated from one another by a tether. Benzyl phenyl sulfoxide [14] was afforded 
in excellent yield (92%) and enantioselectivity (89% ee) using this oxidizing system.  
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Figure 3 Bolm's Ligand and Trimeric Variant prepared by Pati 
 
Khiar and Fernandez (85) reported the first study on asymmetric oxidation of functionalized 
sterically hindered disulfides. Excellent enantioselectivities (up to 96% ee) were obtained 
using the carbohydrate ligand [78].  
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A number of research groups have used sterically bulky ligands in vanadium-catalyzed 
oxidations. Berkessel et al. (86) used ligands [79] and [80] to oxidize thioanisole [16] and 
ortho-bromo thioanisole [81], producing the corresponding sulfoxides in good enantiopurities 
(up to 78%). Although these ligands possess two elements of chirality, the extra chiral feature 
does not affect the stereoselectivity of the oxidation, and stereoselectivity was determined 
only by the chiral centre of the amino alcohol moiety.  
Katsuki et al. (87) used a modified version of Berkessel’s ligand [82] in the oxidation of 
thioanisole [16], producing the corresponding sulfoxide [17] in good yield (83%) and good 
enantioselectivity (86% ee). An addition of methanol resulted in improved enantioselectivity 
(88% ee). Katsuki speculated that coordination of methanol affected the equilibrium of the 
peroxo vanadium species.     
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Ahn et al. (88,89) synthesized a number of ligands that were based on [79]. The use of [83] 
as chiral ligand afforded benzyl phenyl sulfoxide [14] in excellent enantiopurity (96% ee). 
Ahn demonstrated that a chiral centre was required in the imine to achieve asymmetric 
induction as only racemic sulfoxide was generated using [84].  
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Zhu et al. (90) reported asymmetric sulfoxidation using vanadium complexes composed of 
salen ligands such as [85]. A solvent study indicated that CHCl3 was optimal for the 
oxidation, while hydrogen peroxide was used as oxidant. Salen ligand [85] was used to 
catalyze the oxidation of a range of sulfides, affording sulfoxides in good yields (up to 86%) 
and excellent enantioselectivities (up to 95% ee), in certain cases. 
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2.2.1 Synthesis of biologically active sulfoxides using vanadium complexes 
A vanadium complex composed of Schiff base [57] was used to oxidize sulfide [86] 
producing sulfoxide [87] in excellent yield (91%) but moderate enantioselectivity (45% ee). 
Similarly, oxidation of bis-sulfide [88] using ligand [57] afforded the bis-sulfoxide [89], (-)-
diptocarpidin, in poor enantioselectivity (91) (28% ee, Scheme 18). Both sulfoxides exhibit 
antihypoxic activity. 
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Scheme 18 Synthesis of Biologically Active Sulfoxides using a Vanadium Complex 
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Nishi et al. (92) used a vanadium complex with ligand [57] to prepare sulfoxide [90], a key 
intermediate in the synthesis of a tachykinin receptor anatagonist, in good yield (80%) and 
moderate enantioselectivity (54% ee). 
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90  
®-Modafinil [48] was prepared in moderate yield (45%) and poor enantioselectivity (12% ee) 
using a vanadium-catalyzed sulfoxidation, employing [60] as chiral ligand (93). 
2.3 Manganese complexes 
In the last two decades there have been numerous reports of the use of manganese-salen 
complexes in asymmetric sulfoxidation. 1n 1992, Jacobsen et al. (94) used manganese 
complex [91] to catalyze sulfide oxidation but only very modest enantioselectivities were 
achieved. Quici et al. (95) used manganese complexes [92] and [93], which are composed of 
quadridentate Schiff base ligands, for asymmetric sulfoxidation. These ligands are derived 
from 1,2-diamines and fluorous derivatives of salicylaldehyde. Chiral ligands [92] and [93] 
were tested in the oxidation of methyl aryl sulfides, using iodosylbenzene as oxidant, but 
afforded the corresponding sulfoxides in poor enantiopurities (up to 17% ee).  
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Gao et al. (96) investigated the use of manganese complexes bearing a pyrollidine backbone 
such as [94]. However, only modest enantioselectivities were achieved (up to 42% ee). 
Iodosylbenzene was used as oxidant as the use of hydrogen peroxide led to catalyst 
decomposition, while m-CPBA afforded significant amounts of sulfone. The best results were 
obtained for electron-deficient substrates such as para-nitrophenyl methyl sulfide [95].  
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Hirotsu et al. (97) used dimanagnese(III) complexes composed of salen ligands [96] for the 
oxidation of thioanisole [16] reporting modest enantioselectivities (up to 39% ee). Iglesias et 
al. (98) used manganese complex [97] for the asymmetric oxidation of [16], but again 
enantioselectivities achieved were poor (up to 27% ee).    
O
OH
OH
N
N
O
HO
HO
N
N
R
R
96 97
N N
NN
H H
Mn
H2O
Cl
HH
 
Fontecave et al. (99) synthesized manganese complexes bearing perchlorate or 
acetylacetenoate anions. The use of chiral ligand [98] afforded the sulfoxide of thioanisole 
[17] in very poor enantioselectivity (~ 5% ee). However, use of its derivative [99] led to 
improved asymmetric induction (up to 62% ee). Interestingly, the configuration of the 
sulfoxide was dependant on the metal source used, with Mn(ClO4)2 producing the (S)-
enantiomer while the use of Mn(acac)2 gave the ®-enantiomer. 
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Katsuki et al. (32,100) has obtained the best results in manganese-catalyzed asymmetric 
sulfoxidation. Manganese complex [100] was used to oxidize ortho-nitrophenyl methyl 
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sulfide [101], producing the corresponding sulfoxide [102] in moderate yield and excellent 
enantioselectivity as shown in Scheme 19. 
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Scheme 19 Katsuki Oxidation  
Subsequently, Katsuki (33) reported improved yields and enantioselectivities using 
manganese complex [103]. Sulfoxide [102] was now produced in quantitative yield and 
excellent enantioselectivity (up to 94% ee). The addition of 4-phenylpyridine N-oxide to the 
oxidizing system resulted in improved enantioselectivities in certain cases. 
 
 
 
 
 
 
2.3.1 Synthesis of biologically active sulfoxides using manganese complexes 
In 2008, Ryu et al. (101) reported the asymmetric oxidation of omeprazole sulfide [36] using 
a manganese complex [104]. Esomeprazole [1] was afforded in moderate yield and good 
enantioselectivity as shown in Scheme 20. This system was also used to oxidize a range of 
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aryl alkyl sulfides, producing para-nitrophenyl methyl sulfoxide [105] in good yield (76%) 
and good enantioselectivity (80% ee).  
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Scheme 20 Synthesis of Esomeprazole using a Manganese Complex 
2.4 Copper complexes 
Copper complexes of proline based ligands [106] and [107] have been used by Sanchez et al. 
(98) to oxidize thioanisole [16] using NaOCl as oxidant, producing sulfoxide [17] in poor 
enanantioselectivty (up to 25% ee). These complexes exhibited similar chemo- and 
stereoselectivities but lower activies compared to their manganese analogs. Sanchez et al. 
(102) also reported the preparation of enantioenriched aryl methyl sulfoxides (up to 30% ee) 
using immobilized copper(II) salen-type complexes and TBHP as oxidant. 
Cross et al. (103) oxidized [16] using the copper salen complex [108], producing sulfoxide 
[17] in poor enantioselectivity (up to 14% ee). 
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Zhu et al. (104) used complexes composed of optically active Schiff bases such as [109]. 
These afforded sulfoxides in good yields (> 80%) but poor enantioselectivities (up to 17% 
ee). 
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Maguire et al. (105,106) has reported the highest enantioselectivities achieved in copper-
catalyzed asymmetric sulfide oxidation. A series of chiral Schiff bases were used to oxidize a 
number of aryl benzyl sulfoxides in modest yield (up to 49%) but good enantioselectivity (up 
to 81% ee) (105). The addition of N-methylmorpholine-N-oxide (NMO) to the oxidizing 
system resulted in an improvement in yield in all cases and an improvement in 
enantioselectivity in certain cases. This system is similar to Bolm’s vanadium- (65) and iron-
catalyzed oxidations (107,108) in that the same oxidant and similar ligands are employed. 
Interestingly, the direction of stereoselectivity observed is opposite to that observed for 
iron/vanadium-catalyzed oxidations. Recently, Maguire et al. (106) reported a dramatic 
improvement in yields and also an improvement in enantioselectivities using mixed solvent 
systems (Scheme 21). Carrying out the oxidation in mixtures composed of polar, low 
molecular weight alcohols such as methanol or ethanol in conjuction with a non-polar alkane 
such as hexane produced sulfoxides in excellent yields (up to 92%) and excellent 
enantioselectivities (up to 93% ee). Schiff base ligands [110] and [111] produced the best 
results. Interestingly, the use of bulkier alcohols such as isopropyl alcohol (IPA) afforded 
only racemic sulfoxide. A direct relationship between the steric bulk of the sulfide 
substituents and the enantioselectivity of the oxidation was observed. 
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Scheme 21 Asymmetric Oxidation of Sulfides using a Copper Complex 
 
2.5 Iron complexes 
In 2003, Bolm (107) reported an iron-catalyzed asymmetric sulfoxidation. This system was 
based on the vanadium methodology in that the same oxidant and Schiff base ligands were 
employed. The initial results were poor both in terms of yield and enantioselectivity; the 
sulfoxide of thioanisole [17] was produced in low yield (36%) and moderate 
enantioselectivity (59% ee). However, the use of additives led to an improvement in the 
efficiency of the oxidation (108,109). The oxidation of thioanisole [16], in the presence of 
lithium 4-methoxybenzoate, afforded sulfoxide [17] in moderate yield (63%) and excellent 
enantioselectivity (90% ee). Similar improvements were obtained for a range of aryl alkyl 
sulfides. As with vanadium, the use of Schiff base ligands with (S)-configuration produced 
sulfoxides with (S)-configuration and vice versa. 
A number of research groups have reported the use of iron porphyrins in asymmetric 
sulfoxidation. Groves and Viski (110) used vaulted naphthyl metalloporphyrins with 
iodosylbenzene as oxidant. This system produced ortho-bromo phenyl sulfoxide in good 
yield (74%) and moderate enantioselectivity (48% ee). Naruta et al. (111,112) employed iron 
complexes of “twin coronet” porphyrins as the catalyst and iodosylbenzene as oxidant 
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producing sulfoxides in modest enantioselectivities (up to 31% ee). A dramatic improvement 
in enantioselectivity (up to 73% ee) was obtained when the oxidation was carried out in the 
presence 1-methylimidazole at –15 °C. It is believed that the 1-methylimidazole binds to the 
active metal centre and enhances the enantioselectivity by changing the porphyrin structure 
around the iron which prevents decomposition of the catalyst. Inoue et al. (113) also reported 
enhanced enantioselectivity on carrying out an iron porphyrin-catalyzed catalyzed oxidation 
in the presence of imidazole. This system was used to oxidize methoxymethyl phenyl sulfide 
[112] producing the corresponding sulfoxide [113] in good enantioselectivity (Scheme 22). 
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Scheme 22 Iron Porphyrin-Catalyzed Asymmetric Oxidation of Sulfides 
Le Maux et al. (114) recently reported the asymmetric oxidation of sulfides using chiral 
water-soluble iron porphyrins [114] as catalysts. Excellent conversions and 
enantioselectivities were obtained for a range of aryl methyl sulfides. When the oxidation was 
carried out in the presence of 2-methylimidazole there was a slight improvement in 
enantioselectivity but a reduction in yield (Scheme 23). 
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Bryliakov and Talsi (115) reported the use of Fe(III)-salen systems, such as [115], for the 
oxidation of a range of sulfides. This system produced benzyl phenyl sulfoxide [14] in 
excellent conversion (91%) and moderate enantioselectivity (62% ee).  
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Egami and Katsuki (116,117) reported improved enenatioselectivities using salen derivatives, 
such as [116], bearing chiral binaphthyl fragments. This system used hydrogen peroxide as 
oxidant and water as solvent, and was used to oxidize a number of aryl alkyl and methyl alkyl 
sulfides (Scheme 24). 
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Scheme 24 Asymmetric Sulfoxidation using an Iron Salen Derivative 
Fontecave et al. (118) formed an iron complex using the chiral bipyridyl derivative [117]. 
However, the application of this complex to the oxidation of aryl methyl sulfides, afforded 
essentially racemic sulfoxides.  
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117  
2.5.1 Synthesis of biologically active sulfoxides using iron complexes 
Bolm (119) applied the iron-mediated oxidation system to the asymmetric synthesis of 
sulindac [47] (Scheme 25). In the absence of additives, sulfoxide [46] was obtained in 
moderate yield (53%) and enantioselectivity (58% ee). 
34 
 
S
F
S
F
S
F CH2CO2H
Fe(acac)3
, H2O2
 
(35%)
25
 °C,
 
CH2Cl2
46 47
71%
 
Yield
92%
 ee
O O
I
I
OH N
OH
O
HO
OMe
 
Scheme 25 Asymmetric Synthesis of Sulindac using an Iron Complex 
Ternois et al. (93) reported an iron-catalyzed asymmetric sulfoxidation in the synthesis (R)-
modafinil [48]; however poor yields (10%) and enantioselectivities (15% ee) were obtained. 
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2.6 Aluminum complexes 
A highly efficient aluminium-catalyzed oxidation was reported by Katsuki et al. (120). The 
aluminium complex [118] was used to oxidize a number of sulfides, affording sulfoxides 
such [119] and [26] in good yields and excellent enantioselectivities as shown in Scheme 26. 
This oxidizing system is superior to many established methods because the solvent and 
oxidant used make this a very green reaction. High enantioselectivities were maintained 
under modified reaction conditions such as low catalyst loadings and high substrate 
concentrations. 
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Scheme 26 Asymmetric Sulfoxidation using an Aluminum Catalyst 
A number of bicyclic sulfur compounds [120-125] were also oxidized using [118] affording 
the corresponding sulfoxides in excellent enantiopurities (87-99% ee) (121). 
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2.7 Niobium complexes 
Katsuki et al. (122) has also investigated the asymmetric oxidation of sulfides using niobium 
complexes. The use of salen complex [126] afforded the highest enantioselectivities (up to 
86% ee). This system used urea-hydrogen peroxide adduct as oxidant and the addition of 
molecular sieves was necessary to achieve high enantiopurites. The best results were 
achieved with ethyl phenyl sulfide [127], with sulfoxide [128] produced in moderate yield 
and excellent enantioselectivity as shown in Scheme 27.   
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Scheme 27 Asymmetric Sulfoxidation using an Niobium Catalyst 
 
2.8 Tungsten complexes 
In 2003, Sudalai et al. (123) reported a tungsten-catalyzed asymmetric sulfoxidation, 
affording sulfoxides in moderate enantiopurities (up to 65% ee). The cinchona alkaloid 
derivative [129] was used as the chiral ligand and hydrogen peroxide was used as oxidant. 
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2.9 Osmium complexes 
In 2005, Kantam et al. (124) carried out asymmetric sulfoxidation of aryl alkyl sulfides using 
an OsO4 catalyst supported on layered double hydroxides, a cinchona alkaloid derivative and 
NMO as co-oxidant. Sulfoxide [17] was afforded in moderate yield (67%) and 
enantioselectivity (51% ee) using this system.  
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2.10 Molybdenum complexes 
There have been numerous reports of molybdenum-catalyzed asymmetric sulfoxidation in 
recent years. Complexes prepared from Mo(acac)2 and bis-hydroxamic acids, such as [130], 
and trityl hydrogen peroxide (THP) as oxidant, afforded sulfoxides with good yields (66–
99%) and enantiopurities (54–86% ee), in certain cases. An increase in the amount of oxidant 
and reaction time resulted in a considerable enhancement in enantioselectivities (92–99% ee), 
as a result of kinetic resolution (125). 
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Molybdenum complexes composed of cyclodextrin derived ligands [131] and [132] were 
used to oxidize aryl alkyl sulfides, with hydrogen peroxide as oxidant. Modest 
enantioselectivities were obtained (35–65% ee) (126).  
Bonchio et al. (127) used a molybdenum complex composed of a cyclodextrin derived ligand 
[133] in the oxidation of thioanisole [16], affording sulfoxide [17] in excellent yield (98%) 
and moderate enantioselectivity (60% ee). A biphasic solvent system (water-DCE) was 
employed to overcome racemic oxidation by MoO(O2)2 which is also present in the reaction 
mixture. 
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3. Non-metal based systems in asymmetric sulfoxidation 
3.1 Chiral oxaziridines 
In 1979, Davis et al. (128) reported the use of chiral oxaziridine [134] in asymmetric 
sulfoxidation. Although enantioselectivities were very low (~ 14% ee), this represented the 
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first time an oxaziridine had been used in the preparation of enantioenriched sulfoxides. 
Davis’s study indicated that the relationship between the electrophilic oxygen and the chiral 
centre of the reagent, and the restricted geometry of the oxidizing agent, were important in 
obtaining higher enantioselectivities. 
Davis (129) extended the scope of this methodology to include disulfides and thiosulfinates. 
Sulfoxide [135] was prepared in moderate enantioselectivity (46% ee) using oxaziridine 
[136]. This study indicated that factors controlling the absolute configuration of the product 
and the extent of asymmetric induction were largely steric in nature.   
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In 1984, Davis (130) reported the use of chiral sulfamyloxaziridines in asymmetric 
sulfoxidation. Oxaziridine [137] was used to oxidize sulfide [138], affording sulfoxide [139] 
in moderate enantioselectivity (68% ee) as shown in Scheme 28. 
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Scheme 28 Asymmetric Sulfoxidation promoted by a Chiral Oxaziridine 
Davis speculated that the increased enantioselectivity obtained using 2-sulfonyl and 2-
sulfamylozaziridines, compared with peracids or hydroperoxides, was due to the closer 
proximity of the oxaziridine substituents to the active site. 
In 1989, Davis (131) reported dramatic improvements in enantioselectivities using 
dichlorocamphorylsulfonyloxaziridine [140]. Methyl p-tolyl sulfoxide [6] was obtained in 
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excellent yield (95%) and enantioselectivity (95% ee) using [140]. The uniformily high 
enantioselectivities obatained for a variety of sulfides indicated that factors, other than steric, 
were important using this system. 
Meladinis et al. (132) used a similar camphor-based ozaziridine [141] to oxidize thioanisole 
[16], producing sulfoxide [17] in good yield (85%) and enantioselectivity (79% ee). 
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Binaphthyl-derived oxaziridines, such as [142], have been used to oxidize both dialkyl and 
diaryl sulfides, affording sulfoxides in good yields (up to 86%) and modest to good 
enantiopurities (20% to 80% ee) (133). The configuration of the resulting sulfoxide was 
dependant on the sulfide used. 
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In 1994, Page et al. (134) reported the use of an oxidizing agent, generated in situ, to promote 
asymmetric sulfoxidation. tert-Butyl methyl sulfoxide [143] was generated in good yield 
(83%) and moderate enantiopurity (42% ee) using this system. The use of imine [144] 
afforded sulfoxide [143] with improved yield (quantitative) and enantioselectivity (86% ee) 
(135). A major advantage of this system comes from the simplicity by which [144] can be 
prepared in enantiopure form. 
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Schwan and Pippert (136) asymmetrically oxidized a number of aryl and alkyl 2-
(trimethylsilyl)ethyl sulfides to their corresponding sulfoxides using chiral oxaziridine [140]. 
This system gave superior results to other established asymmetric oxidation methods 
available at the time. The oxidation of sulfide [145] afforded sulfoxide [146] in good yield 
(80%) and excellent enantioselectivity (89% ee) as shown in Scheme 29. A steric effect was 
evident, with sterically bulky sulfides affording sulfoxides with higher enantiopurities. 
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Scheme 29 Asymmetric Sulfoxidation of Sterically Bulky Sulfides using a Chiral 
Oxaziridine 
 In 1999, Bohé et al. (137) used methanesulfonic acid (MSA) and an oxaziridine derived 
from [147] to asymmetrically oxidize thioanisole [16]; however, moderate yields (up to 64%) 
and poor enantioselectivities (up to 44% ee) were obtained. 
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Jennings et al. (138) used optically active N-phosphinoyloxaziridines [148] to promote 
asymmetric sulfide oxidation. 9-Anthryl n-butyl sulfoxide [149] was obtained in good 
enantiopurity (70% ee) using this system. Jennings reported that the configuration at 
phosphorus had little influence on the asymmetric induction. 
In 2005, Schoumacker et al. (139) reported the synthesis of new chiral N-alkyloxaziridines, 
such as [150], for asymmetric sulfoxidation. Although these oxaziridines were initially inert 
towards oxidation, they can be activated by Lewis acids such as zinc chloride. Overall, results 
were modest with enantioselectivities ranging from 22 to 63% ee. 
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3.11 Synthesis of biologically active sulfoxides using chiral oxaziridines 
Chiral oxaziridine [140] was used by Von Unge et al. (50) in the asymmetric oxidation of 
omeprazole sulfide [36], affording esomeprazole [1] in poor enantioselectivity (40% ee), 
which was improved by recrystallization (94% ee). Despite the high enantioselectivities 
obtained, Von Unge focussed instead on a titanium-mediated process for the synthesis of [1] 
as this metal-catalyzed procedure had greater potential to be used in production scale. 
Ternois et al. (93) reported the asymmetric synthesis of modafinil and its derivatives. The use 
of chiral oxaziridine [140] gave superior results to a number of metal-catalyzed systems both 
in terms of yield and enantioselectivity. (S)-Modafinil [48] and (S)-modafinic acid [151] were 
obtained in moderate yields and moderate to good enantioselectivities (66% and 60% ee for  
[48], 47% and 90% ee for [151]). The replacement of CCl4 as solvent with ionic liquid [152], 
resulted in improved yields but a reduction in enantioselectivities (73% and 55% ee for  [48], 
73% and 78% ee for [151]).   
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Avarvari et al. (140) reported the use of chiral oxaziridine [153] for the asymmetric oxidation 
of sulfide [154], a precursor in the synthesis of organic conductors. The inner monosulfoxide 
[155] was isolated in poor enantioselectivity (44% ee) as shown in Scheme 30, which was 
subsequently improved by recrystallization (74% ee). A direct relationship was observed 
between the steric bulk of sulfide substrates and the enantioselectivity of the oxidation, with 
less sterically hindered sulfides oxidized with negligible enantioselectivity. 
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Scheme 30 Synthesis of a Biologically Active Sulfoxide using a Chiral Oxaziridine 
Padmanabhan et al. (141)  used oxaziridine [153] to prepare sulfoxide [156] in excellent yield 
(95%) and good enantioselectivity (75% ee). Sulfoxide [156] is a precursor to CNS 5788 
[157], a neuroprotective agent. 
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3.2 Iodine complexes 
In 2006, Zhdankin et al. (142) used an iodine complex [158], derived from (S)-proline, to 
catalyze the oxidation of methyl p-tolyl sulfide [5]. Sulfoxide [6] was generated in good yield 
but poor enantioselectivity as shown in Scheme 31. 
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Scheme 31 Asymmetric Sulfoxidation promoted by an Iron Complex 
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3.3 Bovine serum albumin 
Sugimoto et al. (143) reported the asymmetric oxidation of a large number of aromatic 
sulfides in the presence of bovine serum albumin (BSA), with sodium metaperiodate as 
oxidant. Although yields and enantioselectivities were generally modest, the oxidation of 
sulfide [159] to produce sulfoxide [160] proceeded with good efficiency as shown in Scheme 
32.  
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Scheme 32 Asymmetric Sulfoxidation using BSA 
Ogura et al. (144) carried out the asymmetric oxidation of dithioacetals in the presence of 
BSA, reporting modest enantioselectivities (up to 60% ee). Colonna et al. (145) carried out a 
similar oxidation to obtain sulfoxide [161] in 69% ee. 
161
S CO2t
-Bu
O
 
3.4 Chiral hydroperoxides and peracids 
Peracids have been known to promote asymmetric sulfoxidation since the 1960s (146).  
Although subsequent publications have reported the use of peracids, such as [162], the 
enantioselectivities achieved have been poor (less than 10% ee) (147). 
Superior results have been achieved using chiral hydroperoxides. Aoki and Seebach (148) 
used hydroperoxide [163] to promote asymmetric sulfoxidation. Sulfoxide [17] was obtained 
in good yield (73%) and enantioselectivity (86% ee) using this method. 
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4. Enzyme-catalyzed asymmetric sulfoxidation 
4.1 Whole cell systems 
The use of whole cell systems to catalyze asymmetric sulfoxidation has been known for many 
decades. In 1962, Dodson et al. (149) reported the oxidation of benzyl phenyl sulfide [13] 
using Aspergillus niger, affording sulfoxide [14] in modest enantiopurity (18% ee). In a later 
report, Boyd et al. (150) described the oxidation of a range of alkyl and aryl benzyl sulfides 
using Aspergillus niger. The enantioselectivity of the oxidation was largely substrate specific, 
with sterically bulky sulfides affording sulfoxides, such as [164], with higher enantiopurities. 
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Holland and co-workers (151-158) have reported the asymmetric oxidation of a large number 
of sulfides by the fungus Helminthosporium species NRRL 4671. Excellent 
enantioselectivities were obtained in certain cases (>96% ee, after recrystallization). Holland 
(158) also employed the fungus Mortierella isabellina for asymmetric sulfoxidation, 
reporting modest to good enantiopurities. Interestingly, the use of Helminthosporium species 
NRRL 4671 produced (S)-sulfoxides, while Mortierella isabellina favoured the production of 
the (R)-enantiomer. 
There have been numerous reports of the use of bacterial cells to promote asymmetric sulfide 
oxidation. In 1969, Argoudelis et al. (159) reported the transformation of lincomycin [165] to 
the corresponding sulfoxide by Streptomyces lincolnensis. 
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Ohta et al. (160-162) also synthesized chiral sulfoxides via microbial oxidation of sulfides. 
Incubation of a range of aryl alkyl sulfides with growing cells of Corynebacterium equi IFO 
3730 afforded sulfoxides with excellent enantioselectivities (up to 100% ee). The length of 
the alkyl chain in the sulfide had a strong influence on the efficiency of the oxidation. While 
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the oxidation of aryl methyl sulfides gave sulfoxides exclusively, a significant amount of 
sulfone accompanied the oxidation of sulfides bearing a long alkyl chain (sulfides [166] and 
[167]). 
S S
166 167  
Ethene-grown Micrococcus sp. M90C was used to catalyze the asymmetric oxidation of 
thioanisole [16], producing sulfoxide [17] in excellent enantioselectivity (> 90% ee) (163). 
A range of aryl alkyl sulfides was oxidized by the topsoil bacterium Pseudomonas 
frederiksbergensis (164). Excellent conversions (100%) and enantioselectivities (> 99% ee) 
were obtained. Sulfides bearing a long alkyl chain were oxidized with a reduction in both 
yield and enantioselectivity.  
Brackenridge et al. (165) reported the asymmetric oxidation of methyl p-tolyl sulfide [5], 
using bakers yeast (Saccharomyces cerevisiae NCYC73). Sulfoxide (R)-[6] was prepared in 
enantiopure form in a 60% yield. 
Kayser et al. (166) also reported the use of engineered yeast in the oxidation of aryl alkyl 
sulfides. Sulfoxide [17] was prepared in excellent yield (95%) and enantioselectivity (99% 
ee). Interestingly, sulfides bearing a para substituent on the phenyl ring, such as [168] and 
[169], were converted to sulfoxides with high enantiopurities (96% ee for [168], 98% ee for 
[169]), albeit with a reduction in yield (45% for [168], 33% ee for [169]). 
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White-rot basidomycetes promote the asymmetric oxidation of sulfides into sulfoxides with 
good enantiopurities and conversions, although minor sulfone production is also observed 
(159). (S)-n-propylphenyl  sulfoxide [170] was obtained in enantiopure form using six 
different forms of Basidomycetes (167). 
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Filamentous fungi Botrytis Cinerea, Eutypa lata and Trichoderma Viride have been used in 
the asymmetric oxidation of sulfides, affording sulfoxides with modest to good 
enantiopurities (168). Oxidations using T. viride and E. lata gave the (R)-sulfoxide, while the 
use of B. cinerea favoured the formation of the (S)-enantiomer.  
Whole cells of the microalga Chlorella sorokiniana were used in the oxidation of a large 
number of sulfides. Overall, modest yields (up to 67%) and enantioselectivities (up to 58% 
ee) were obtained (169). The structure of the sulfide had a strong influence on the efficiency 
of the oxidation, with aryl alkyl sulfoxides generally produced in higher yields and 
enantioselectivities than benzyl alkyl sulfoxides. 
 
4.2 Isolated Enzymes 
There have been numerous reports of the use of a chloroperoxidase (CPO) enzyme in the 
asymmetric oxidation of sulfides. These methods generally differ by the method in which the 
oxidant is generated. Colonna et al. (170) used CPO from the marine fungus Caldariomyces 
fumago, with hydrogen peroxide as oxidant, to catalyze asymmetric sulfoxidation. Sulfoxides 
were produced in good yields and enantiopurities (up to 99% ee). 
Lutz et al. (171) reported the first asymmetric electroenzymatic oxidation catalyzed by a CPO 
enzyme. Hydrogen peroxide is generated in situ by cathodic reduction of oxygen. Overall, 
excellent enantioselectivities were obtained for the oxidation of thioanisole [16] (> 98.5% 
ee). 
Leitner et al. (172) also reported a CPO-catalyzed oxidation of thioanisole [16], affording 
sulfoxide [17] in poor yield (34%) and excellent enantioselectivity (94% ee). The oxidant, 
hydrogen peroxide, was generated in situ directly from hydrogen and oxygen using palladium 
catalysis in supercritical carbon dioxide (sc. CO2). Hydrogen peroxide was then used by the 
CPO enzyme to oxidize thioanisole [16] in the aqueous phase as shown in Figure 4. 
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Figure 4 Asymmetric Electroenzymatic Sulfoxidation 
 
Sulfoxide [17] was afforded in quantitative yield and excellent enantioselectivity (99% ee) in 
a procedure described by Arends et al (173). In this case, hydrogen peroxide was generated 
by light, using flavins as photocatalysts and ethylendiaminetetraacetic acid (EDTA) as an 
electron donor. Unfortunately, the oxidation was accompanied by waste product from EDTA 
such as formaldehyde and ethylenediamine. Replacement of EDTA with formate resulted in 
reduced enantiopurities. 
Allenmark and Andersson (174) carried out asymmetric sulfoxidation using a CPO from 
Caldariomyces fumago and hydrogen peroxide as oxidant. The oxidation of 2,3-
dihydrobenzothiophene [171] proceeded with excellent yield (99.5%) and enantioselectivity 
(99% ee). The introduction of increased steric bulk (sulfides [172] and [173]) or a heteroatom 
(sulfide [174]) to the sulfide resulted in a reduction in yield or a reduction in both yield and 
enantioselectivity relative to sulfoxide [175]. Further studies indicated that sulfides [172] and 
[173] were too sterically demanding to compete for the active site of the enzyme, while 
sulfide [174] acted as a competitive inhibitor of the enzyme. As a result, sulfoxides [175-178] 
were obtained in poor yield as shown in Scheme 33. 
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Scheme 33 Asymmetric Sulfoxidation using a CPO Enzyme 
 
In 1995, Ottolina et al. (175) reported the preparation of enantioenriched sulfoxides by 
asymmetric oxidation, catalyzed by cyclohexanone monooxygenase (CHMO) from 
Acinetobacter NCIB 9871. This system afforded a range of aryl alkyl sulfoxides in excellent 
yields and enantioselectivities. Ottolina established an active site model to explain and 
predict the stereoselectivity of the oxidation.   
 
Ozaki and de Montellano (176,177) reported an efficient horseradish peroxidase (HRP)-
catalyzed asymmetric sulfoxidation. Interestingly, the replacement of phenylalanine-41 with 
leucine increases both the rate and the enantioselectivity of the oxidation. The greatest 
improvement, using this modified enzyme, was observed for cyclopropylmethyl phenyl 
sulfide [179], which is oxidized ten times faster and with an increase in enantioselectivity 
from 7 to 94% ee. Replacement of phenylalanine-41 with threonine resulted in an 
improvement in rate but a reduction in enantioselectivity for the oxidation of thioanisole [16] 
and para-chlorothioanisole [32]. The results indicated that phenylalanine-41 is a major 
determinant of peroxygenase substrate binding in the HRP active site. 
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Wever et al. (178) reported the asymmetric oxidation of [16] using both lactoperoxidase 
(LPO) and Coprinus cinereus peroxidase (CiP), affording sulfoxide [17] in good yields (85% 
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for LPO and 84% for CiP) and enantioselectivities (80% ee for LPO and 73% ee for CiP). 
Interestingly, the use of LPO afforded (R)-[17] while CiP yielded the (S)-enantiomer. Wever 
et al. (179) reported the use of vanadium haloperoxidases in asymmetric sulfoxidation. The 
vanadium bromoperoxidase from the brown seaweed Ascphyllum nodosum afforded (R)-[17] 
in modest yield (55%) and good enantioselectivity (85% ee). The optimum pH range for this 
enzyme was pH 5–6. Interestingly, the vanadium bromoperoxidase from the red seaweed 
Corallina pilulifera afforded sulfoxide (S)-[17] in poor yield (18%) and modest 
enantioselectivity (55% ee), while use of the vanadium chloroperoxidase from the fungus 
Curvularia inaequalis catalyzes the formation of racemic [17] in a 54% yield. Wever (180) 
also used Myeloperoxidase (MPO) to catalyze sulfide oxidation; however, only modest 
enantiopurities were obtained (up to 32% ee). 
Boyd et al. (181) reported the asymmetric oxidation of a series of aryl alkyl sulfides, using 
selected strains of the soil bacterium Pseudomonas putida, containing either toluene 
dioxygenase (TDO) or naphthalene dioxygenase (NDO). Enantioselectivities were excellent 
in most cases (up to >98% ee) although the yields varied significantly. Interestingly, the 
TDO-catalyzed oxidation favoured the (R)-enantiomer while use of NDO favoured the (S)-
enantiomer. Gibson et al. (182) reported similar results for the oxidation of unsubstituted aryl 
alkyl sulfides. However, the presence of substituents at the para position, resulted in a 
reduction in both yield and enantioselectivity (sulfides [25] and [105]).  
4-Hydroxyacetophenone monooxygenase (HAMPO) from Pseudomonas fluorescens ACB 
has been used to catalyze the oxidation of a range of phenyl and benzyl alkyl sulfides (183). 
Excellent conversions (up to 96%) and enantioselectivities (up to 99% ee) were achieved for 
the majority of the phenyl alkyl sulfoxides. However, the oxidation of the benzyl alkyl 
sulfides proceeded with a reduction in both conversion and enantioselectivity. This was in 
contrast to the use of phenylacetone monooxygenase (PAMO) which afforded benzyl alkyl 
sulfoxides with higher enantiopurities than the corresponding phenyl analogues (184). The 
absolute configuration of the products was strongly dependent on the size of the alkyl group, 
using HAMPO, with the (S)-enantiomer predominating in the case of small alkyl substituents, 
wheras a bulkyl alkyl chain resulted in preferential formation of the (R)-enantiomer. 
Allenmark and Andersson (185) used vanadium bromoperoxidase from Corallina officinalis 
in asymmetric sulfide oxidation, with hydrogen peroxide as oxidant. This study indicated that 
sulfides bearing a cis-substituted carboxyl group such as [180] and [181] are oxidized rapidly 
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producing sulfoxides in excellent enantioselectivities (>95% ee). Interestingly, a rapid loss of 
stereoselectivity was observed when the oxidation was carried out in the presence of bromide 
ions.        
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Zhang et al. (186) used a cytochrome P450 monooxygenase in asymmetric sulfoxidation, 
producing sulfoxides [17] and [182] in excellent enantioiselectivities as shown in Scheme 34. 
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Scheme 34 Asymmetric Sulfoxidation using a Cytochrome P450 Monooxygenase Enzyme 
 
Casella et al. (187) reported the asymmetric oxidation of sulfides using mushroom tyrosinase 
in the presence of catechol as co-substrate as shown in Scheme 35. Catechol competes with 
the sulfide in the reaction which limits the efficiency of the process (yields of ~ 20%). 
Casella demonstrated that the mechanism of the sulfoxidation involves oxygen transfer from 
oxy-tyrosinase to the sulfide. 
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Scheme 35 Asymmetric Sulfoxidation using a Tyrosinase Enzyme 
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4.3 Synthesis of biologically active sulfoxides using biological oxidations 
A large number of microorganisms (~650) were tested for their potentiality to convert 
rabeprazole sulfide [183]  to the corresponding sulfoxide [3] (188). A newly isolated strain of 
mold, Cunninghamella echinulata MK 40, gave the best result with [3] produced in 
enantiopure form (S) and in a 92% conversion (Scheme 36). Omeprazole and Lansoprazole 
were also prepared by this method, although the conversions were significantly lower.  
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Scheme 36 Synthesis of Rabeprazole using a Microorganism 
 
Olivo et al. (189) reported the asymmetric synthesis of sulfoxide [151] from 
benzhydralsulfanyl acetic acid [184] using the fungus Beauveria bassiana. Excellent yield 
(89%) and enantioselectivity (99% ee) were obtained as shown in Scheme 37. Sulfoxide 
[151] was then converted to modafinil [48]. 
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Scheme 37 Asymmetric Synthesis of Modafinil using a Fungus 
Hamman et al. (190) reported the use of flavin-dependent monooxygenase 3 (FMO3) to 
prepare enantioenriched sulindac [47] from the corresponding sulfide in 90% ee (R). 
5. Conclusion 
In conclusion, substantial progress has been made over the past two decades in asymmetric 
sulfide oxidation using metal catalysts, enzymatic oxidation and non-metal based systems. 
However, substrate scope remains limited with best results for aryl methyl sulfides. 
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